Exposure to higher indoor radon concentrations may put postmenopausal women at increased risk of heart failure, according to a study.
Researchers used data from the Women’s Health Initiative (WHI) observational study and clinical trials. They identified 43,188 postmenopausal women (mean age 63 years) who did not have self-reported heart failure at baseline.
Indoor radon exposure was determined using geocoded participant address and categorized as follows: <2, 2–4, or >4 picocuries (pCi)/L. Incident hospitalization for acute decompensated heart failure was ascertained through physician adjudication of medical records.
Indoor exposure to a radon concentration was <2 pCi/L in 36 percent of participants, 2–4 pCi/L in 41 percent, and >4 pCi/L in 23 percent. Over a mean follow-up of 16.2 years, 3,446 incident heart failure events occurred.
In the analyses, indoor radon exposure at levels >4 pCi/L vs <2 pCi/L was associated with a 19-percent increased risk of heart failure (adjusted hazard ratio [aHR], 1.19, 95 percent confidence interval [CI], 1.07–1.33). Notably, the risk associated with higher indoor radon exposure was more pronounced for heart failure with reduced ejection fraction (aHR, 1.24, 95 percent CI, 1.04–1.49) and heart failure mortality (aHR, 1.37, 95 percent CI, 1.12–1.69).
The risk of heart failure observed at concentrations >4 pCi/L was similar to the risk associated with major cardiometabolic risk factors, approximating the risk associated with a 16-mm Hg increase in systolic blood pressure or a 4.8-kg/m2 increase in BMI.